Geode Capital Management’s 20/20 Biolabs AIDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AIDX
Geode Capital Management's AIDX Position: Q3 2026 in Review
Geode Capital Management increased its 20/20 Biolabs (AIDX) stake by 11% in Q3 2026, buying an estimated $2.76K and bringing the position to 54,493 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4299.
Geode Capital Management first reported a position in AIDX in Q2 2026 and has held it in 2 quarters since. The position peaked at $27K in Q2 2026. 16 funds tracked by Wall St. Rank hold AIDX as of Q3 2026.
- Geode Capital Management held 54,493 shares of 20/20 Biolabs worth $23.8K as of Q3 2026.
- Geode Capital Management bought 5,352 20/20 Biolabs shares in Q3 2026, an estimated $2.76K.
- 20/20 Biolabs made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4299 holding.
- Geode Capital Management first reported a position in 20/20 Biolabs in Q2 2026 and has held it in 2 quarters since.
- Geode Capital Management's 20/20 Biolabs position peaked at $27K in Q2 2026.
- 16 funds tracked by Wall St. Rank held 20/20 Biolabs as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.